Recent 8-K filings for PNTG

• May 20, 2026, 4:02 PM ET other material materiality 0.15 neutral item 5.07item 9.01

  Pennant Group annual meeting elects three Class I directors, ratifies auditor, approves say-on-pay

  Three Class I directors elected: Christensen (21.6M for), Guerisoli (22.6M for), Nackel (21.7M for).

• May 6, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01 ◈ Earnings Releases

  Pennant Group Q1 GAAP EPS $0.24, revenue $285.4M (+36%); adjusted EPS $0.32

  GAAP diluted EPS $0.24; adjusted diluted EPS $0.32, up 33% YoY.

• February 25, 2026, 6:59 PM ET earnings materiality 0.80 positive item 2.02item 7.01item 9.01

  Pennant Group Q4 revenue $289.3M (+53% YoY); FY2025 GAAP EPS $0.84, adjusted EPS $1.18

  Full year revenue $947.7M (+36.3% YoY); net income $29.6M (+31.1% YoY).

• December 17, 2025, 6:59 PM ET M&A materiality 0.65 neutral item 9.01

  Pennant Group closes acquisition of Amedisys/UnitedHealth home health assets; files FY2024 audited financials

  Acquisition of home health/hospice subsidiaries from UnitedHealth and Amedisys closed on October 1, 2025.

• November 5, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Pennant Group Q3 revenue up 26.8% to $229M; adjusted EPS $0.30; completes 54-location acquisition

  GAAP diluted EPS $0.17; adjusted diluted EPS $0.30; adjusted net income $10.4M (+27.6% YoY).

• November 5, 2025, 6:59 PM ET debt materiality 0.55 positive item 1.01item 2.03item 9.01 ◈ Debt Financings

  Pennant Group expands credit facility by $100M to $350M via incremental term loan

  Incremental term loan A of $100M added to existing credit facility, increasing total to $350M.

• October 2, 2025, 7:59 PM ET M&A materiality 0.85 positive item 7.01item 9.01

  Pennant closes $146.5M purchase of 54 home health/hospice locations in TN, GA, AL from UnitedHealth

  Purchase price $146.5M; trailing twelve-month revenue of acquired operations $189.3M.

• October 2, 2025, 7:59 PM ET M&A materiality 0.75 neutral item 2.01item 7.01item 9.01 ◈ M&A Transactions

  Pennant completes $146.5M acquisition of 54 home health/hospice locations from UnitedHealth/Amedisys

  Acquisition includes home health, hospice and personal care operations in Tennessee, Georgia and Alabama.

• October 2, 2025, 7:59 PM ET M&A materiality 0.75 positive item 1.01item 9.01

  Pennant Group expands home health/hospice acquisition from UnitedHealth, purchase price rises to $146.5M

  Purchase price increased from $102.5M to $146.5M via First Amendment; adds entities and locations.

• August 6, 2025, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 7.01item 9.01

  Pennant Q2 2025: GAAP EPS $0.20, adjusted $0.27; revenue up 30.1% to $219.5M

  Net income $7.1M (+24.5% YoY); adjusted net income $9.4M (+28.2%); adjusted EBITDA $16.4M (+24.5%).

• May 20, 2025, 7:59 PM ET other material materiality 0.15 neutral item 5.07item 9.01

  Pennant Group annual meeting passes all proposals; director and say-on-pay see notable dissent

  Class III director Stephen M.R. Covey elected with 17,627,587 votes for (69%); 8,061,411 against.

• May 6, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Pennant Group Q1 GAAP EPS $0.22, revenue up 33.7% to $209.8M; beats prior year substantially

  GAAP diluted EPS $0.22; adjusted diluted EPS $0.27; net income $7.8M (+58.5% YoY).

• May 1, 2025, 7:59 PM ET M&A materiality 0.70 positive item 1.01

  Pennant Group to acquire home health/hospice assets from UnitedHealth/Amedisys for $102.5M

  Acquisition price $102,484,000, subject to pre- and post-closing adjustments, paid in cash.

• February 27, 2025, 6:59 PM ET earnings materiality 0.65 positive item 2.02item 7.01item 9.01

  Pennant Group Q4/FY2024: revenue up 27.6% to $695M; adj. EPS $0.94

  GAAP diluted EPS $0.70 full year, $0.16 Q4; adjusted diluted EPS $0.94 full year, $0.24 Q4.

• January 2, 2025, 6:59 PM ET M&A materiality 0.75 positive item 2.01item 9.01

  Pennant completes $48.5M Oregon acquisition of Signature Healthcare at Home

  Oregon portion closed Jan 1, 2025; total two-stage acquisition now complete.

• November 6, 2024, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Pennant Group Q3 net income up 42% to $6.2M; revenue rises 29% to $180.7M

  GAAP diluted EPS $0.20; adjusted diluted EPS $0.26 for Q3 2024.

• October 4, 2024, 7:59 PM ET other material materiality 0.65 neutral item 1.01item 9.01

  Pennant Group closes public offering of 4,025,000 shares, net proceeds ~$118.5M

  Issued 4,025,000 shares at a public offering, including full underwriter option exercise of 525,000 shares.

• August 6, 2024, 7:59 PM ET earnings materiality 0.85 positive item 2.02item 7.01item 9.01

  Pennant Q2 revenue up 27.6% to $168.7M; EPS $0.18, adj. EPS $0.24

  GAAP diluted EPS $0.18; adjusted diluted EPS $0.24. Net income $5.7M (+103.4% YoY).

• August 1, 2024, 7:59 PM ET debt materiality 0.65 positive item 1.01item 2.03item 9.01

  Pennant Group increases credit facility by $100M to $250M, extends maturity to 2029

  New $250M credit facility replaces prior $150M facility, adding $100M in borrowing capacity.

• July 11, 2024, 7:59 PM ET M&A materiality 0.75 positive item 8.01item 9.01

  Pennant Group agrees to buy Signature Healthcare at Home assets for $80M

  $80M purchase price covers affiliates in OR, WA, ID; two separate purchase agreements.

• May 29, 2024, 7:59 PM ET other material materiality 0.15 neutral item 5.07item 9.01

  Pennant Group annual meeting results: all director nominees elected, say-on-pay passes

  Scott E. Lamb elected with 18.9M for, 2.4M against; Morris 19.8M for, 1.5M against; Smith 14.4M for, 7.0M against.

• May 6, 2024, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01 ◈ Earnings Releases

  Pennant Group Q1 2024: revenue $156.9M (+24%), adj EPS $0.20, net income up 165%

  GAAP EPS $0.16, adjusted EPS $0.20; adjusted net income $6.0M up 55% YoY.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.75 · Most common event earnings

16 positive 0 negative 6 neutral

source · PNTG on sec.gov